05:35 PM EDT, 03/20/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) appointed Erick Lucera as chief financial officer, effective March 31.
Lucera, 57, was previously CFO at Editas Medicine ( EDIT ) , Dyne Therapeutics ( DYN ) said Thursday in a regulatory filing.
Separately, Editas named Amy Parison as CFO, effective March 28.
Parison, 39, most recently was senior vice president, finance, Editas said Thursday in a filing.